{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26295746", "DateCompleted": {"Year": "2015", "Month": "12", "Day": "22"}, "DateRevised": {"Year": "2015", "Month": "09", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "08", "Day": "21"}], "ELocationID": ["10.1021/acs.jnatprod.5b00234"], "Language": ["eng"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "78", "Issue": "9", "PubDate": {"Year": "2015", "Month": "Sep", "Day": "25"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Natural \u03b2-Dihydroagarofuran-Type Sesquiterpenoids as Cognition-Enhancing and Neuroprotective Agents from Medicinal Plants of the Genus Celastrus.", "Pagination": {"StartPage": "2175", "EndPage": "2186", "MedlinePgn": "2175-86"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is an irreversible, multifaceted, and progressive neurodegenerative disorder. Over the past 30 years, the search for anti-AD drugs has been primarily based on the cholinergic deficiency hypothesis and/or the \u03b2-amyloid (A\u03b2) cascade hypothesis. In this study, we report the identification of 16 new and 38 known \u03b2-dihydroagarofuran-type sesquiterpenoids from Celastrus flagellaris and Celastrus angulatus. The \u03b2-dihydroagarofuran-type sesquiterpenoids 58, 59, 61, and 63 significantly attenuated scopolamine-induced prolonged escape latency and increased number of errors compared with the control group. At 10 \u03bcM, 21 of the 62 tested \u03b2-dihydroagarofuran-type sesquiterpenoids rescued A\u03b225-35-induced SH-SY5Y cells from viability reduction, which increased the cell viability from 64.6% for the model to more than 74.0%. The majority of the \u03b2-dihydroagarofuran-type sesquiterpenoids with ester groups exhibited stronger activity than those with free hydroxy groups or without substituents at the same positions. These results identified a new chemical skeleton as drug lead for the investigation of novel therapeutic agents against AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Ning", "ForeName": "Ruonan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Lei", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Liu", "ForeName": "Shuangzhu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Wang", "ForeName": "Huan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Rujun", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Wang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Zhu", "ForeName": "Yingdong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Haiyan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, People's Republic of China."}], "LastName": "Zhao", "ForeName": "Weimin", "Initials": "W"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Esters"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptide Fragments"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "amyloid beta-protein (25-35)"}, {"RegistryNumber": "20053-66-1", "NameOfSubstance": "dihydroagarofuran"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["drug effects"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Celastrus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cognition"}, {"QualifierName": [], "DescriptorName": "Esters"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Nuclear Magnetic Resonance, Biomolecular"}, {"QualifierName": ["drug effects"], "DescriptorName": "Peptide Fragments"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Sesquiterpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2015", "Month": "8", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "12", "Day": "23", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26295746", "10.1021/acs.jnatprod.5b00234"]}}], "PubmedBookArticle": []}